Ramsey Cheung
Academic Appointments
- Professor - Med Center Line, Medicine - Gastroenterology & Hepatology
- Member, Cancer Center
Contact Information
-
Clinical Offices
Gastroenterology & Hepatology Clinic 900 Blake Wilbur Dr W3045 MC 5309 Stanford, CA 94305 Tel Work (650) 498-6920 Fax (650) 725-8418
Professional Snapshot
Clinical Focus
- Gastroenterology
- Hepatology (Liver)
Administrative Appointments
- Director, Fellowship in GI & Hepatology, Stanford (2004 - present)
- Chief of Hepatology, VAPAHCS (1999 - present)
- Associate Director, Fellowship in GI & Hepatology, Stanford (2002 - 2004)
- Director of Endoscopy, VAPAHCS (1997 - 1998)
- Chief of Gastroenterology, VA-Livermore (1993 - 1995)
Honors and Awards
- Teaching Award, Department of Medicine (2002, 2004, 2006, 2007)
Professional Education
| Board Certification: | Gastroenterology, American Board of Internal Medicine (1991) |
| Fellowship: | SUMC - Graduate Medical Education, CA (1991) |
| Board Certification: | Internal Medicine, American Board of Internal Medicine (1986) |
| Residency: | UCI College of Medicine, CA (1985) |
| Internship: | UCI College of Medicine, CA (1983) |
Postdoctoral Advisees
Scientific Focus
Research Interests
Dr. Cheung's past research utilized the duck animal model to study the mechanism of viral neutralization of hepatitis B virus at the molecular level. In collaboration with basic scientists, he is interested in using molecular biology approaches to study clinical samples from chronic hepatitis C patients and investigate the host-virus interaction. The ultimate goal is to understand the pathogenesis of HCV and mechanism of anti-viral therapy. Dr. Cheung is also investigating the healthcare model of hepatitis C care among infected veterans, interaction between hepatitic C infection and alcoholic cirrhosis, and impact of comorbid conditions on the health related quality of life. He is investigating methods to improve care of veterans with chronic hepatitis C, including use of the novel experimental anti-viral therapies as part of clinical trails. Dr. Cheung also used VA and other database to study various healthcare issues in patients with chronic hepatitis C.
Clinical Trials
- Blood Sample Study of viral and Immune Responses to Treatment in People with HIV or Hepatitis C Infections Recruiting
- Clinical and Pathologic Studies in Non-Hodgkin's Lymphoma and Hodgkin's Disease Recruiting
- Study of Nitazoxanide, Peginterferon Alfa-2a and Ribavirin for the Treatment of Hepatitis C No longer recruiting
Publications
- The impact of chronic hepatitis C and co-morbid illnesses on health-related quality of life. Qual Life Res. 2008; (5): 715-24
- A 7 gene signature identifies the risk of developing cirrhosis in patients with chronic hepatitis C. Hepatology. 2007; (2): 297-306
- Incidence of statin hepatotoxicity in patients with hepatitis C. Clin Gastroenterol Hepatol. 2006; (7): 902-7; quiz 806
- Epidemiology of hepatitis C virus infection in American veterans. Am J Gastroenterol. 2000; (3): 740-7
- Adenovirus-induced acute liver failure. Dig Dis Sci. 2009; (2): 218-21
Help